Physician profile
Brad Rogers
NPI 1538275102
$1,398.52
in general payments reported to CMS, 2019-2025
24 companies · $37.40 in 2025
The $37.40 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $169 · 2021: $334 · 2022: $117 · 2023: $219 · 2024: $124 · 2025: $37.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $171.52 | 2019-2024 | Xtandi |
| Abbvie INC. | $168.33 | 2019-2023 | Lupron Depot |
| Janssen Biotech, INC. | $166.19 | 2019-2024 | Erleada |
| Myriad Genetic Laboratories, INC. | $138.33 | 2020-2023 | Prolaris |
| Olympus America INC. | $99.29 | 2021-2023 | Olympus |
| Myovant Sciences INC. | $68.77 | 2021-2022 | |
| Photocure INC | $65.21 | 2021-2024 | Cysview |
| Portola Pharmaceuticals, LLC | $49.73 | 2019 | |
| Ferring Pharmaceuticals INC. | $49.11 | 2019 | |
| Sumitomo Pharma America, INC. | $47.96 | 2023-2024 | Orgovyx, Gemtesa |
| Ambu INC. | $41.92 | 2020 | |
| Boston Scientific Corporation | $40.65 | 2019-2020 | |
| Antares Pharma, INC. | $38.58 | 2019-2021 | |
| Telix Pharmaceuticals | $37.40 | 2025 | Illuccix |
| Axonics, INC. | $36.69 | 2023-2024 | Axonics, Bulkamid |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $34.27 | 2021-2024 | Keytruda |
| Profound Medical Corp. | $23.85 | 2021 | |
| Hollister Incorporated | $22.52 | 2023 | Infyna Chic |
| Karl Storz Endoscopy-America | $20.41 | 2019 | |
| 180 Medical, INC. | $17.88 | 2019 | |
| Dentsply Ih INC. | $15.73 | 2021 | |
| Cook Medical LLC | $15.26 | 2021 | |
| Pfizer INC. | $14.92 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.